Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Morin, C. M. Articles by Vallières, A. Search for Related Content PubMed Citation Articles by Morin, C. M. Articles by Vallières, A. Related Article

Randomized Clinical Trial of Supervised Tapering and Cognitive Behavior Therapy to Facilitate Benzodiazepine Discontinuation in Older Adults With Chronic Insomnia

OBJECTIVE: This study evaluated the effectiveness of a supervised benzodiazepine taper, singly and combined with cognitive behavior therapy, for benzodiazepine discontinuation in older adults with chronic insomnia. METHOD: Seventy-six older adult outpatients (38 women, 38 men; mean age of 62.5 years) with chronic insomnia and prolonged use (mean duration of 19.3 years) of benzodiazepine medication for sleep were randomly assigned for a 10-week intervention consisting of a supervised benzodiazepine withdrawal program (N=25), cognitive behavior therapy for insomnia (N=24), or supervised withdrawal plus cognitive behavior therapy (N=27). Follow-up assessments were conducted at 3 and 12 months. The main outcome measures were benzodiazepine use, sleep parameters, and anxiety and depressive symptoms. RESULTS: All three interventions produced significant reductions in both the quantity (90% reduction) and frequency (80% reduction) of benzodiazepine use, and 63% of the patients were drug-free within an average of 7 weeks. More patients who received medication taper plus cognitive behavior therapy (85%) were benzodiazepine-free after the initial intervention, compared to those who received medication taper alone (48%) and cognitive behavior therapy alone (54%). The patients in the two groups that received cognitive behavior therapy perceived greater subjective sleep improvements than those who received medication taper alone. Polysomnographic data showed an increase in the amount of time spent in stages 3 and 4 sleep and REM sleep and a decrease in total sleep time across all three conditions from baseline to posttreatment. Initial benzodiazepine reductions were well maintained up to the 12-month follow-up, and sleep improvements became more noticeable over this period. No significant withdrawal symptoms or adverse events were associated with benzodiazepine tapering. CONCLUSIONS: A structured, time-limited intervention is effective in assisting chronic users of benzodiazepine medication to discontinue or reduce their use of medication. The addition of cognitive behavior therapy alleviates insomnia, but sleep improvements may become noticeable only after several months of benzodiazepine abstinence.

Related Article:

In This Issue
Am J Psychiatry 2004 161: A70. [Full Text] [PDF]

This article has been cited by other articles:

				D. J. Buysse Chronic Insomnia Am J Psychiatry, June 1, 2008; 165(6): 678 - 686. [Full Text] [PDF]

				W. Gorgels, R. Oude Voshaar, A. Mol, E. van de Lisdonk, J Mulder, H van den Hoogen, A. van Balkom, M. Breteler, and F. Zitman Consequences of a benzodiazepine discontinuation programme in family practice on psychotropic medication prescription to the participants Fam. Pract., October 1, 2007; 24(5): 504 - 510. [Abstract] [Full Text] [PDF]

				R. C. O. Voshaar, J. E. Couvee, A. J. L. M. Van Balkom, P. G. H. Mulder, and F. G. Zitman Strategies for discontinuing long-term benzodiazepine use: Meta-analysis The British Journal of Psychiatry, September 1, 2006; 189(3): 213 - 220. [Abstract] [Full Text] [PDF]

				A M. Clarfield Review: sedative hypnotics increase adverse effects more than they improve sleep quality in older persons with insomnia Evid. Based Med., August 1, 2006; 11(4): 110 - 110. [Full Text] [PDF]

				W. Gorgels, R. Oude Voshaar, A. Mol, E. van de Lisdonk, A. van Balkom, M. Breteler, H. van den Hoogen, J Mulder, and F. Zitman Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice Fam. Pract., February 1, 2006; 23(1): 65 - 72. [Abstract] [Full Text] [PDF]

				R. C. O. VOSHAAR, W. J. M. J. GORGELS, A. J. J. MOL, A. J. L. M. VAN BALKOM, J. MULDER, E. H. VAN DE LISDONK, M. H. M. BRETELER, and F.G. ZITMAN Long-term outcome of two forms of randomised benzodiazepine discontinuation The British Journal of Psychiatry, February 1, 2006; 188(2): 188 - 189. [Abstract] [Full Text] [PDF]

				M. H. Silber Chronic Insomnia N. Engl. J. Med., August 25, 2005; 353(8): 803 - 810. [Full Text] [PDF]

				P. G O'Malley CBT added to tapering helped patients with chronic insomnia discontinue benzodiazepine use Evid. Based Med., September 1, 2004; 9(5): 147 - 147. [Full Text] [PDF]

				J. SAREEN, M. W. ENNS, and B. J. COX Potential for Misuse of Sedatives Am J Psychiatry, September 1, 2004; 161(9): 1722 - 1723. [Full Text] [PDF]

				Other articles noted Evid. Based Ment. Health, August 1, 2004; 7(3): 67 - 68. [Full Text] [PDF]

				Other articles noted: 06 Feb 2004 to 16 Apr 2004 Evid. Based Nurs., July 1, 2004; 7(3): e3 - e3. [Full Text] [PDF]

				Sleepless Seniors: Banish Benzos Journal Watch Women's Health, March 23, 2004; 2004(323): 6 - 6. [Full Text]

				J. Rosack Med Check Psychiatr News, March 19, 2004; 39(6): 72 - 74. [Full Text]

				Treat Older Benzodiazepine-Dependent Insomniacs with Supervised Tapering Plus CBT Journal Watch Psychiatry, March 10, 2004; 2004(310): 7 - 7. [Full Text]

				Discontinuing Benzodiazepines in Older Adults with Chronic Insomnia Journal Watch (General), March 2, 2004; 2004(302): 4 - 4. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us